| Typicality: | 0.506 |
| Saliency: | 0.600 |
| currently | 40 | temporal |
| with other advanced or metastatic cancers | 13 | other |
| in china | 12 | location |
| trial → recruit → patient | 123 |
| trial → recruit → new patients | 3 |
| negative | neutral | positive |
| 0.084 | 0.818 | 0.098 |
| Raw frequency | 126 |
| Normalized frequency | 0.600 |
| Modifier score | 0.500 |
| Perplexity | 491.942 |